Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association Between Use of β-Blockers and Prostate Cancer-specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.: Beta-blockers and Prostate Cancer Survival - Interpretation of Competing Risks Models.


Bhaskaran, K; Rachet, B; Evans, S; Smeeth, L; (2013) Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association Between Use of β-Blockers and Prostate Cancer-specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.: Beta-blockers and Prostate Cancer Survival - Interpretation of Competing Risks Models. European urology, 64 (4). e86-7. ISSN 0302-2838 DOI: 10.1016/j.eururo.2013.07.004

Full text not available from this repository. (Request a copy)
Item Type: Article
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Non-Communicable Disease Epidemiology
Faculty of Epidemiology and Population Health > Dept of Medical Statistics
Research Centre: Centre for Global Non-Communicable Diseases (NCDs)
Cancer Survival Group
PubMed ID: 23895794
Web of Science ID: 323939900006
URI: http://researchonline.lshtm.ac.uk/id/eprint/1110856

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
385Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item